How Banking Reform Would Reshape Cannabis Retail

August 18, 2026

Photo via Pexels.

A dispensary in Oakland moving $300,000 a month in receipts will pay something like $54,000 a year just to get that cash into an account it can actually use. Not because anyone suspects fraud, not because the money is dirty, but because the plant it sells remains a Schedule I substance under federal law, and federally chartered banks won't touch Schedule I proceeds without pricing in the risk of a Bank Secrecy Act violation. That fee is a straightforward tax on federal illegality, and it lands on legitimate, state-licensed operators exactly the same whether they're a single storefront or a twelve-state multi-state operator.

Congress has tried to fix this before. SAFE Banking is back again in 2026 -- S. 4942 and its House companion H.R. 9471 -- and it's worth saying plainly that this is not a fresh idea catching momentum for the first time. It's the latest entry in a pattern that has now repeated across three consecutive congresses: the House passes something like it, and the Senate lets it die without a floor vote. That pattern matters more than any single bill number, and we'll get into exactly why below.

There's also a widespread and understandable confusion happening in coverage right now, which is treating the Blanche Order's move of marijuana to Schedule III as though it solves the banking problem. It doesn't, and conflating rescheduling with banking reform is probably the single most common factual error being made about cannabis policy at the moment. This piece is an attempt to separate three categories cleanly: what's already established fact as of mid-2026, what's a reasonable, evidence-based bet if the current bill moves, and what remains genuine speculation that shouldn't be reported as anything more than that.

Where SAFE Banking Actually Stands in Mid-2026

Photo via Unsplash.

The current vehicle is S. 4942, filed by Sen. Jeff Merkley (D-OR) on June 24, 2026, with a House companion, H.R. 9471, filed the following day by Rep. Dave Joyce (R-OH). Both bills carry cosponsor lists built specifically to signal bipartisan durability rather than partisan messaging -- in the Senate that means Elizabeth Warren, Lisa Murkowski, and Steve Daines attached to the same text, an odd-bedfellows combination that's been fairly consistent across SAFE Banking's various incarnations since 2019. The House side lists Jim Himes, Warren Davidson, Nydia Velázquez, Brian Mast, Lou Correa, Guy Reschenthaler, and Dina Titus as cosponsors, spanning both parties and covering members from states with mature legal markets and states with none at all.

Why Rescheduling Doesn't Solve the Banking Problem

Photo via Pexels.

Rescheduling and banking reform get treated as one story in a lot of coverage, and they are not the same story at all -- they're two separate legal tracks moving at two separate speeds, governed by different statutes entirely. The Blanche Order, effective April 28, 2026, moved a narrow slice of marijuana -- FDA-approved marijuana products and marijuana used in qualifying state medical programs -- to Schedule III. That's a real, consequential change for tax treatment and research access, but it is explicitly limited in scope; it does not touch the broader adult-use retail market that makes up the bulk of dispensary revenue nationally.

What Cash Dependency Actually Costs a Dispensary Today

Photo via Pexels.

Strip away the policy debate for a moment and look at what cash dependency actually costs a licensed retailer running a normal month, because these are present-tense operating expenses, not hypothetical projections. California cannabis retailers report monthly banking fees running $2,000 to $7,500 for basic account access with a cannabis-friendly bank or credit union, and that's before adding cash deposit fees that typically run 0.5% to 2.0% of every dollar deposited. Run the math on a mid-sized dispensary moving $300,000 a month and you land at roughly $54,000 a year in fees just to convert the store's own receipts into usable, depositable funds -- money that, at a normally banked retailer in any other regulated industry, would simply sit in an account for free or near-free.

ACH Rails: The Workaround Already Reshaping Retail

Cannabis transactions processed through ACH rails are projected to rise from 28% in 2025 to 42% in 2026, reflecting growing adoption of this payment method in the industry.

While Congress stalls, the industry has been quietly building its own workaround, and it's growing fast enough that it deserves attention on its own terms. Industry payment-processing estimates suggest ACH transactions -- direct bank-to-bank transfers that route around the merchant-category-code restrictions card networks impose on plant-touching businesses -- could account for roughly 42% of cannabis retail transactions in 2026, up from about 28% in 2025. That's a meaningful one-year jump in payment infrastructure for an industry that was almost entirely cash-based just a few years ago, and it's happening without any change in federal law at all.

What Retail Actually Looks Like If SAFE Banking Passes

Photo via Pexels.

Assume, for a moment, that S. 4942 actually clears the Senate floor this time and gets signed. What changes for a typical dispensary the following year? The direct, mechanical case is straightforward: a genuine safe harbor lets banks and credit unions serve cannabis retailers without fear of federal banking-law enforcement, which should compress or eliminate those $2,000-$7,500 monthly account fees and, more importantly, open access to conventional business credit lines instead of the private cannabis lenders currently charging 12% to 24% interest on working capital. That's the difference between financing a build-out or inventory expansion like any other small retailer and financing it like a business operating in a legal gray zone.

If you want one number to track instead of a bill number, track this: has the Senate scheduled any floor vote on cannabis banking reform at all. Not a committee markup, not a hearing, an actual floor vote. That single procedural step has failed to happen for three consecutive congresses despite House passage seven times and a 14-9 Senate Banking Committee vote in a prior session, and nothing about S. 4942's cosponsor list -- however genuinely bipartisan -- changes the Senate calendar math or the floor-time priorities of leadership in either party. Watch for that vote, not for optimistic quotes from sponsors.

Keep the two tracks separate in your own thinking, because conflating them is exactly the mistake this piece opened with. Rescheduling under the Blanche Order and whatever the DEA Administrator eventually decides after Judge Julius's recommendation is a tax and research question, governed by federal drug-scheduling mechanics. Banking access is a separate financial-regulation question, governed by an entirely different set of agencies -- FinCEN, the OCC, the FDIC, the Federal Reserve -- none of which had issued cannabis-specific guidance revisions tied to the rescheduling order as of mid-2026. Don't expect a DEA scheduling decision, however it comes down, to unlock a bank account.

The most honest leading indicator sitting in front of us right now is ACH adoption, precisely because it moves independent of Congress. It climbed from roughly 28% to 42% of transaction share in a single year without any legislative help, and it will likely keep climbing whether SAFE Banking passes or not, simply because it's cheaper and faster than armored cash transport. The real marker of legislative success, if it ever comes, won't be a press release -- it'll be the moment ACH and cashless workarounds stop being the industry's best available option and become just one option among several normal ones, including plain commercial deposit accounts and conventional credit. That's a genuinely different retail landscape, and right now it's still speculation, not fact.